4-phenoxypiperidine
CAS No. 3202-33-3
4-phenoxypiperidine( —— )
Catalog No. M21097 CAS No. 3202-33-3
4-phenoxypiperidines with muscle relaxant and anticonvulsant activities.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 28 | In Stock |
|
| 10MG | 29 | In Stock |
|
| 25MG | 51 | In Stock |
|
| 50MG | 75 | In Stock |
|
| 100MG | 112 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | 276 | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product Name4-phenoxypiperidine
-
NoteResearch use only, not for human use.
-
Brief Description4-phenoxypiperidines with muscle relaxant and anticonvulsant activities.
-
Description4-phenoxypiperidines with muscle relaxant and anticonvulsant activities.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number3202-33-3
-
Formula Weight177.24
-
Molecular FormulaC11H15NO
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESc1ccc(OC2CCNCC2)cc1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
-
26-Deoxycimicifugosi...
26-Deoxycimicifugoside is a natural product from Cimicifuga foetida L.
-
Chitinase, Serratia ...
Chitinase, Serratia marcescens (EC 3.2.1.14) has partial lysozyme activity and is widely found in bacteria, fungi, animals and some plants. Chitinase belongs to the glycosyl hydrolase family. Chitinase catalyzes chito-oligosaccharide hydrolysis. Chitinases also can serve as prognostic biomarkers of disease progression. Chitinase can be used in the research of pathogenesis of various human fibrotic and inflammatory disorders, particularly those of the lung (idiopathic pulmonary fibrosis, chronic obstructive pulmonary disease, sarcoidosis, and asthma) and the gastrointestinal tract (inflammatory bowel diseases (IBDs) and colon cancer).
-
α-santonin
α-santonin is a potent antiparasitic agent.
Cart
sales@molnova.com